Date published: 2026-6-26

1-800-457-3801

SCBT Portrait Logo
Seach Input

SPINK5L2 Inhibitors

SPINK5L2 inhibitors are a class of chemical compounds that interact with the serine protease inhibitor Kazal-type 5-like 2 protein, commonly referred to by its abbreviation SPINK5L2. This protein belongs to a larger family of serine protease inhibitors which are characterized by their ability to bind to and inhibit the function of serine proteases. Serine proteases are a type of enzyme that cleaves peptide bonds in proteins, playing a critical role in various physiological processes by their involvement in digestion, immune response, blood coagulation, and cellular turnover. SPINK5L2 inhibitors are designed to selectively bind to the SPINK5L2 protein, thereby modulating its activity. The inhibition of this particular serine protease inhibitor can affect the balance of proteolytic activity within the body, as SPINK5L2 itself is part of a complex regulatory mechanism that ensures proteases are active only where and when they are needed.

The chemical structure of SPINK5L2 inhibitors can be diverse, yet they share the common trait of being able to specifically interact with SPINK5L2. This specificity is achieved through the inhibitor's ability to mimic the natural substrates of the protease or to fit into the reactive site of the protein, thus preventing the SPINK5L2 from binding to the serine protease it normally regulates. The design of these inhibitors often involves a deep understanding of the structural biology of SPINK5L2, including the shape and charge distribution of its active and binding sites. Researchers may use various techniques such as X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy to determine the precise arrangement of atoms within the SPINK5L2 protein. With this information, inhibitors can be tailored to interact with the protein with high affinity and selectivity. The development of SPINK5L2 inhibitors also considers the pharmacokinetic properties of the compounds, ensuring that they are stable and can reach the site of the SPINK5L2 protein in adequate concentrations to exert their modulatory effect.

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

Palbociclib is a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6), which are crucial for cell cycle progression. By inhibiting these kinases, Palbociclib could lead to indirect inhibition of SPINK5L2 if SPINK5L2 is linked to cell cycle control.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib is a proteasome inhibitor that prevents the degradation of proteins involved in cell cycle control and apoptosis. If the degradation of regulatory proteins by the proteasome affects SPINK5L2 function, then bortezomib could indirectly inhibit SPINK5L2 activity.